Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 0 | 0 | 0 | 0 | 10,637 |
| Gross Profit | N/A | N/A | 0 | N/A | 10,637 |
| Operating Expenses | 16,005 | 17,251 | 15,923 | 16,916 | 19,984 |
| Operating Income | -16,005 | -17,251 | -15,923 | -16,916 | -9,347 |
| Interest Expense | 9 | 10 | 12 | 19 | 15 |
| Other Income | 665 | -197 | 2,675 | 645 | 19 |
| Pre-tax Income | -15,349 | -17,458 | -13,260 | -16,290 | -9,343 |
| Net Income Continuous | -15,349 | -17,458 | -10,015 | -16,290 | -9,343 |
| Net Income | $-15,349 | $-17,458 | $-10,015 | $-16,290 | $-9,343 |
| EPS Basic Total Ops | -0.31 | -0.35 | -0.18 | -0.34 | -0.20 |
| EPS Basic Continuous Ops | -0.31 | -0.35 | -0.19 | -0.34 | -0.20 |
| EPS Diluted Total Ops | -0.31 | -0.35 | -0.18 | -0.34 | -0.20 |
| EPS Diluted Continuous Ops | -0.31 | -0.35 | -0.19 | -0.34 | -0.20 |
| EBITDA(a) | $-15,555 | $-16,812 | $-15,502 | $-16,494 | $-8,905 |